Arthrex ABS-2014-10Recalls & reported problems
Isotis Orthobiologics, Inc. · AlloSync CB DBM Putty, 10cc Vial · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10889981153694), received between Jul 29, 2021 and May 21, 2024 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Patient Device Interaction Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Patient Device Interaction Problem2
- Insufficient Device Problem Information1
- Patient-Device Incompatibility1
Patient problems
- Unspecified Infection3
- Swelling/ Edema2
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryMay 21, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED THE PATIENT WAS 3 WEEKS OUT FROM ACL TUNNEL BONE GRAFTING WITH DOWELS PROCEDURE WHICH OCCURRED ON (B)(6) 2021. THAT WAS THE FIRST STAGE OF A REVISION FROM AN ACL PROCEDURE FROM YEARS AGO. DURING THE FIRST FOLLOW UP A WEEK POST OP ON (B)(6) 2021 THE PATIENT HAD MILD PAIN AND MODERATE SWELLING. ON (B)(6) THE PATIENT WENT TO THE EMERGENCY DEPARTMENT REPORTING THE SWELLING AND PAIN HAS INCREASED. ON (B)(6) 2021 HE CAME IN TO SEE THE DOCTOR AND THE EXAM REPORTED ACTIVE DRAINAGE OVER THE INCISION AND WAS DIAGNOSED WITH AN INFECTION. IT WAS DETERMINED ALL OF THE IMPLANTED ITEMS WILL NEED TO BE REMOVED INCLUDING THE ALLOSYNC PUTTY AND TWO DOWELS. ADDITIONAL INFORMATION: THE DOWELS (NOT AN ARTHREX ITEM) WERE REAMED OUT ALONG WITH THE PUTTY. THE ONLY ARTHREX PRODUCT REMOVED DURING THIS PROCEDURE WAS THE ABS-2014-10.
Patient problems: Unspecified Infection
MAUDE report 19357818 ↗InjuryJan 5, 2024Patient-Device Incompatibility; Patient Device Interaction Problem; Patient-Device Incompatibility; Patient Device Interaction Problem
ON (B)(6) 2021, AN ACL TUNNEL BONE GRAFT WITH DOWELS PROCEDURE WAS PERFORMED. THE PROCEDURE WAS THE 1ST STAGE REVISION OF A SURGERY THAT OCCURRED SEVERAL YEARS PRIOR. ON (B)(6) 2021 AT A FOLLOW UP, THE PATIENT COMPLAINED OF MILD PAIN AND MODERATE SWELLING. ON (B)(6) 2021, THE PATIENT WAS SEEN IN AN EMERGENCY ROOM REPORTING INCREASED SWELLING AND PAIN. ON (B)(6) 2021, THE PATIENT FOLLOWED UP WITH THEIR PROVIDER AND WAS DIAGNOSED WITH AN INFECTION. IT WAS DETERMINED THAT ALL THE ITEMS IMPLANTED WOULD NEED TO BE REMOVED, INCLUDING THE ABS-2014-10 ALLOSYNC CB DBM PUTTY, 10CC AND 2 DOWELS. THE DOWELS ARE NOT ARTHREX ITEMS. THE EVENTS DESCRIBED ABOVE WERE PREVIOUSLY INACCURATELY REPORTED THROUGH REPORT NUMBER 3012120772-2021-00068. THIS REPORT IS ISSUED TO RECTIFY THIS MISTAKE AND SUBSTITUTE THE PRIOR REPORT FILED UNDER THE INCORRECT REGISTRY.
Patient problems: Swelling/ Edema; Unspecified Infection
MAUDE report 18455850 ↗MalfunctionJul 29, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
ON (B)(6) 2021, AN ACL TUNNEL BONE GRAFT WITH DOWELS PROCEDURE WAS PERFORMED. THE PROCEDURE WAS THE 1ST STAGE REVISION OF A SURGERY THAT OCCURRED SEVERAL YEARS PRIOR. ON (B)(6) 2021 AT A FOLLOW UP, THE PATIENT COMPLAINED OF MILD PAIN AND MODERATE SWELLING. ON (B)(6) 2021, THE PATIENT WAS SEEN IN AN EMERGENCY ROOM REPORTING INCREASED SWELLING AND PAIN. ON (B)(6) 2021, THE PATIENT FOLLOWED UP WITH THEIR PROVIDER AND WAS DIAGNOSED WITH AN INFECTION. IT WAS DETERMINED THAT ALL THE ITEMS IMPLANTED WOULD NEED TO BE REMOVED, INCLUDING THE ABS-2014-10 ALLOSYNC CB DBM PUTTY, 10CC AND 2 DOWELS. THE DOWELS ARE NOT ARTHREX ITEMS.
Patient problems: Swelling/ Edema; Unspecified Infection
MAUDE report 12250400 ↗
Other Filler, bone void, osteoinduction (w/o human growth factor) devices
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T45010Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)2 recalls2 reports
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T44135Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)2 recalls1 report
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T44115Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)2 recalls1 report
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T42210Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)2 recalls0 reports
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T42100Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)2 recalls0 reports
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T45001Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)2 recalls0 reports
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T45005Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)2 recalls0 reports
- GRAFTON®and GRAFTON PLUS®Demineralized Bone Matrix (DBM) T43105Medtronic Sofamor Danek, Inc. · Filler, bone void, osteoinduction (w/o human growth factor)1 recall4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page